Author Search Results :: Library Catalog

1
Bile acids and probiotics could help treating diabetes by Calasan, J., Al-Salami, Hani, Mikov, M.

Published 2012

Get full text
QR Code
2
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaem... by Mathavan, S., Mikov, M., Golocorbin-Kon, S., Al-Salami, Hani

Published 2017

Get full text
QR Code
3
Probiotics applications in autoimmune diseases by Al-Salami, Hani, Caccetta, Rima, Golocorbin-Kon, S., Mikov, M.

Published 2012

Get full text
QR Code
4
Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics by Al-Salami, Hani, Butt, G., Tucker, I., Mikov, M.

Published 2008

Get full text
QR Code
5
Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring by Maksimovic, V., Golocorbin-Kon, S., Hogervorst, J., Al-Salami, Hani, Mikov, M.

Published 2017

Get full text
QR Code
6
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats by Al-Salami, Hani, Butt, G., Tucker, I., Golocorbin-Kon, S., Mikov, M.

Published 2012

Get full text
QR Code
7
Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring by Golocorbin-Kon, S., Mikov, M., Cvejic Hogervorst, J., Al-Salami, Hani, Maksimovic, V.

Published 2018

Get full text
QR Code
8
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study by Mooranian, A., Negrulj, R., Mikov, M., Golocorbin-Kon, S., Arfuso, Frank, Al-Salami, Hani

Published 2015

Get full text
QR Code
9
Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats by Al-Salami, Hani, Butt, G., Tucker, I., Skrbic, R., Golocorbin-Kon, S., Mikov, M.

Published 2008

Get full text
QR Code
10
Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration by Lalic-Popovic, M., Vasovic, V., Al-Salami, Hani, Golocorbin-Kon, S., Milijasevic, B., Mikov, M.

Published 2013

Get full text
QR Code
11
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat by Lalic-Popovic, M., Vasovic, V., Milijasevic, B., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.

Published 2013

Get full text
QR Code
12
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid by Mooranian, A., Zamani, N., Mikov, M., Golocorbin-Kon, S., Stojanovic, G., Arfuso, Frank, Al-Salami, Hani

Published 2018

Get full text
QR Code
13
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminish... by Golocorbin-Kon, S., Calasan, J., Milijasevic, B., Vukmirovic, S., Lalic-Popovic, M., Mikov, M., Al-Salami, Hani

Published 2017

Get full text
QR Code
14
Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses by Mooranian, A., Zamani, N., Mikov, M., Golocorbin-Kon, S., Stojanovic, G., Arfuso, Frank, Al-Salami, Hani

Published 2018

Get full text
QR Code
15
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome by Danic, M., Stanimirov, B., Pavlovic, N., Golocorbin-Kon, S., Al-Salami, Hani, Stankov, K., Mikov, M.

Published 2018

Get full text
QR Code
16
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles by Pavlovic, N., Golocorbin-Kon, S., Danic, M., Stanimirov, B., Al-Salami, Hani, Stankov, K., Mikov, M.

Published 2018

Get full text
QR Code
17
The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes by Mikov, M., Ðanic, M., Pavlovic, N., Stanimirov, B., Golocorbin-Kon, S., Stankov, K., Al-Salami, Hani

Published 2017

Get full text
QR Code
18
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics by Mikov, M., Ðanic, M., Pavlovic, N., Stanimirov, B., Golocorbin-Kon, S., Stankov, K., Al-Salami, Hani

Published 2017

Get full text
QR Code
19
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats by Al-Salami, Hani, Butt, G., Tucker, I., Fawcett, P., Golocorbin-Kon, S., Mikov, I., Mikov, M.

Published 2009

Get full text
QR Code
20
Lamotrigine and valproate pharmacokinetics interactions in epileptic patients by Lalic, M., Cvejic, J., Popovic, J., Bozic, K., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.

Published 2009

Get full text
QR Code

Search Results - Mikov, M.

Bile acids and probiotics could help treating diabetes by Calasan, J., Al-Salami, Hani, Mikov, M.

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaem... by Mathavan, S., Mikov, M., Golocorbin-Kon, S., Al-Salami, Hani

Probiotics applications in autoimmune diseases by Al-Salami, Hani, Caccetta, Rima, Golocorbin-Kon, S., Mikov, M.

Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics by Al-Salami, Hani, Butt, G., Tucker, I., Mikov, M.

Dried Blood Spot: Utilizing Dry Blood For Pharmacokinetic Investigations—An Old Method with Great Future for Therapeutic Drug Monitoring by Maksimovic, V., Golocorbin-Kon, S., Hogervorst, J., Al-Salami, Hani, Mikov, M.

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats by Al-Salami, Hani, Butt, G., Tucker, I., Golocorbin-Kon, S., Mikov, M.

Dried blood spot: Utilising dry blood for pharmacokinetic investigations - An old method with great future for therapeutic drug monitoring by Golocorbin-Kon, S., Mikov, M., Cvejic Hogervorst, J., Al-Salami, Hani, Maksimovic, V.

Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study by Mooranian, A., Negrulj, R., Mikov, M., Golocorbin-Kon, S., Arfuso, Frank, Al-Salami, Hani

Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats by Al-Salami, Hani, Butt, G., Tucker, I., Skrbic, R., Golocorbin-Kon, S., Mikov, M.

Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration by Lalic-Popovic, M., Vasovic, V., Al-Salami, Hani, Golocorbin-Kon, S., Milijasevic, B., Mikov, M.

Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat by Lalic-Popovic, M., Vasovic, V., Milijasevic, B., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.

Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid by Mooranian, A., Zamani, N., Mikov, M., Golocorbin-Kon, S., Stojanovic, G., Arfuso, Frank, Al-Salami, Hani

High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminish... by Golocorbin-Kon, S., Calasan, J., Milijasevic, B., Vukmirovic, S., Lalic-Popovic, M., Mikov, M., Al-Salami, Hani

Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses by Mooranian, A., Zamani, N., Mikov, M., Golocorbin-Kon, S., Stojanovic, G., Arfuso, Frank, Al-Salami, Hani

Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome by Danic, M., Stanimirov, B., Pavlovic, N., Golocorbin-Kon, S., Al-Salami, Hani, Stankov, K., Mikov, M.

Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles by Pavlovic, N., Golocorbin-Kon, S., Danic, M., Stanimirov, B., Al-Salami, Hani, Stankov, K., Mikov, M.

The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes by Mikov, M., Ðanic, M., Pavlovic, N., Stanimirov, B., Golocorbin-Kon, S., Stankov, K., Al-Salami, Hani

Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics by Mikov, M., Ðanic, M., Pavlovic, N., Stanimirov, B., Golocorbin-Kon, S., Stankov, K., Al-Salami, Hani

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats by Al-Salami, Hani, Butt, G., Tucker, I., Fawcett, P., Golocorbin-Kon, S., Mikov, I., Mikov, M.

Lamotrigine and valproate pharmacokinetics interactions in epileptic patients by Lalic, M., Cvejic, J., Popovic, J., Bozic, K., Golocorbin-Kon, S., Al-Salami, Hani, Mikov, M.

Search Tools: